‘Big Short’ Michael Burry just revealed his latest stock bets

On August 12, Michael Burry – the hedge‑fund manager whose 2008 short on sub‑prime mortgages turned him into a cult figure – disclosed a fresh batch of trades that juxtapose long bets in a veterinary‑drug maker with a cascade of short positions across the AI‑heavy technology sector. The contrast is stark: while Burry bought Zoetis (ZTS) at $73.60 per share, he simultaneously deepened his bearish outlook on AI‑driven firms such as Micron (MU), Oracle (ORCL), the iShares Semiconductor ETF (SOXX) and a fledgling AI‑chip player, Nebius (NBIS). The moves arrive just days after a 5.6% dip in MercadoLibre (MELI) and a 30% slide in Zoetis earlier this year, suggesting Burry is hunting for valuation dislocations rather than chasing momentum.

Why does this matter? Burry’s reputation for spotting macro‑level mispricing gives weight to his claim that the AI “boom” may be built on fragile financing structures. He has warned that the rapid influx of capital into AI hardware and cloud services is creating circular financing loops – where large cloud providers fund smaller AI startups that, in turn, purchase the providers’ own chips and services. To Burry, this mirrors the accounting opacity that helped bring down Enron, a comparison he reiterated when criticizing Nvidia’s (NVDA) recent institutional‑capital initiative.

From a market‑behavior perspective, Burry’s bets could foreshadow a recalibration of AI valuations. Companies that have surged on speculative hype – for example, Nebius, which jumped 34% in a single day – may face heightened scrutiny if investors begin to demand clearer revenue reporting. The broader implication is a potential slowdown in technology‑driven automation adoption, as firms reassess the cost‑benefit balance of AI‑enabled workflows.

Structurally, Burry’s portfolio highlights a divergence between traditional, cash‑flow‑positive businesses and fast‑growing, yet often unprofitable, AI players. Zoetis, a steady producer of veterinary medicines, offers predictable earnings and a modest dividend, providing a defensive anchor in a volatile tech landscape. In contrast, his short positions target firms whose growth narratives rely heavily on future‑year capital commitments and opaque accounting for cloud‑based services.

Real‑world implications are already surfacing. Investors in AI‑focused ETFs may see increased volatility, prompting portfolio managers to diversify away from pure‑play AI exposure. Meanwhile, corporate finance teams at AI startups could feel pressure to improve transparency around capital use, especially as institutional investors echo Burry’s concerns about “circular financing.”

Beyond the immediate trades, Burry’s stance connects to a larger industry trend: the push toward automation and workflow transformation is encountering a fiscal reality check. Companies that can demonstrate tangible productivity gains without relying on perpetual funding rounds are likely to emerge as the new standard‑bearers for technology adoption.

In sum, Burry’s latest moves serve as a reminder that even in a market awash with AI optimism, disciplined valuation analysis and scrutiny of financing structures remain essential. Whether his short bets trigger a broader reassessment of AI hype or simply represent a contrarian outlier, they inject a needed dose of caution into an otherwise exuberant sector.